Full Text View
Tabular View
No Study Results Posted
Related Studies
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
This study has been terminated.
( Terminated )
Study NCT01150890   Information provided by Amgen

First Received on June 24, 2010.   Last Updated on September 22, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crohn's Disease
Additional conditions recognized in this trial
Crohn Disease
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Interventions listed in this trial
AMG 827 350 MG
AMG 827 210 MG
AMG 827 700 MG
Placebo
Sponsors listed in this trial
Amgen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services